UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Discover effective wealth management strategies tailored for young adults. Start building your wealth for a prosperous future.
21,049 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Pi Network misses its upgrade deadline as the v23 rollout stalls. The PI token slides below key support, leaving inve...
A new executive directive directs the Federal Reserve to reassess whether non-bank fintech and crypto firms can acces...
Through mid-May 2026, VXUS has risen about 10% year-to-date, narrowly surpassing the S&P 500’s roughly 8% gain. The m...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Southern Land Company unveils SLC Lending, an in-house mortgage division, to streamline financing for buyers across i...
Stellantis unveiled a bold €60 billion turnaround plan at Investor Day, aiming to reshape costs, cash flow, and a mod...
Analysts warn that grok could undermine spacex as AI bets shape risk appetite for a potential SpaceX IPO. Investors a...
Grab is accelerating its push into physical AI and automated driving, testing robots in Singapore and at its own offi...
Recent data mixed with geopolitics have rattled markets. This article explains what it means for stock market investo...
Chevron sits at the heart of today’s energy debate: steady production, looming supply gaps, and the question every in...